Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
BIOSYENT INC (V.RX) had Consolidated Net Income/Loss of 1.26M for the most recently reported fiscal quarter, ending 2018-06-30.
| Income Statement Financials | |
-- |
|
1.26M |
|
-- |
|
-- |
|
-- |
|
1.58M |
|
-- |
|
1.64M |
|
1.64M |
|
1.26M |
|
1.26M |
|
|
Consolidated Net Income/Loss |
1.26M |
1.26M |
|
1.58M |
|
1.61M |
|
14.51M |
|
14.55M |
|
0.09 |
|
0.09 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
21.93M |
|
-- |
|
-- |
|
-- |
|
2.42M |
|
19.51M |
|
18.01M |
|
19.51M |
|
14.52M |
|
| Cash Flow Statement Financials | |
1.53M |
|
-7.53M |
|
0.04M |
|
9.80M |
|
3.82M |
|
-5.98M |
|
0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
77.04% |
|
34.50% |
|
34.50% |
|
-- |
|
35.85% |
|
27.42% |
|
1.52M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.78 |
|
2.31 |
|
39.02 |
|
6.43% |
|
6.97% |
|
5.72% |
|
6.43% |
|
1.73 |
|
0.10 |
|
0.11 |
|